드러그인포 약품요약정보

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

644500030[A02003841] [보험코드에 따른 약품기본정보 직접조회]
\0 원/1정(2006.11.01)(현재약가)
\65 원/1정(2003.12.01)(변경전약가)
[상병코드조회]
[질병코드조회]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

백색 내지 유백색 원형 정제 [제형정보 확인]

포장·유통단위

10, 50, 100, 500정

포장·코드단위

약품규격	단위	포장형태	대표코드	표준코드	비고
250밀리그램	500 정	병	8806445000306	8806445000344
250밀리그램	168 정	병	8806445000306	8806445000337
250밀리그램	112 정	병	8806445000306	8806445000320
250밀리그램	36 정	PTP	8806445000306	8806445000313

주성분코드

283000ATB [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]

허가사항 원문조회

[허가사항 원문조회]

효능효과

[적응증 별 검색]

위산과다, 속쓰림, 위부불쾌감, 위부팽만감, 식체(위체), 구역, 구토, 위통, 신트림

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
용법용량용법용량
성인 1회 4정 1일 3회 식간에 씹어서 복용한다.

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

금기

투석요법을 받고 있는 환자

Related FDA Approved Drug

기준 성분:MAGNESIUM CARBONATE
RENACIDIN (CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE)
기준 성분:ALUMINIUM HYDROXIDE AND MAGNESIUM CARBONATE DRIED

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
성분코드	M083647/수산화알루미늄탄산마그네슘혼합건조겔 250밀리그램 / M040629/탄산마그네슘 80밀리그램 /
주성분코드	283000ATB [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]
대표코드	8806445000306
BIT 약효분류	제산제 & 흡착제 (Antacids & Adsorbents)
ATC 코드	Ordinary salt combinations / A02AD01 [코드분류상세설명] [ATC코드예측]
복지부분류코드	234 (제산제 )
의약품 바코드정보	내용보기 개비콘에스정/A02003841 제품규격:/제품수량:36/제형:정 폼목기준코드:199700380 /대표코드:8806445000306/표준코드:8806445000313 구바코드:-/비고:- 개비콘에스정/A02003841 제품규격:/제품수량:112/제형:정 폼목기준코드:199700380 /대표코드:8806445000306/표준코드:8806445000320 구바코드:-/비고:- 개비콘에스정/A02003841 제품규격:/제품수량:168/제형:정 폼목기준코드:199700380 /대표코드:8806445000306/표준코드:8806445000337 구바코드:8806046001122/비고:- 개비콘에스정/A02003841 제품규격:/제품수량:500/제형:정 폼목기준코드:199700380 /대표코드:8806445000306/표준코드:8806445000344 구바코드:8806046001115/비고:-
주성분코드 분석 및 중복처방 검토	[주성분코드 분석 및 중복처방 검토]
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	644500030[A02003841] [보험코드에 따른 약품기본정보 직접조회] \0 원/1정(2006.11.01)(최신약가) \65 원/1정(2003.12.01)(변경전약가) [상병코드조회] [질병코드집 다운로드]
제품성상	백색 내지 유백색 원형 정제 [제형정보 확인]
포장·유통단위	10, 50, 100, 500정
보관방법	기밀용기, 건조한 곳에 보관
동일주성분코드 검색순위	유료정보입니다.

복약정보

항목	내용
LACTmed 바로가기	[바로가기]
축약복약지도	유료정보입니다.
복약지도	유료정보입니다.
Pharmacokinetics	유료정보입니다.
보관상 주의
조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Magnesium에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Aluminium에 대한 Mechanism_Of_Action 정보 Aluminum Acetate is an astringent. An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application. The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied. Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot. magnesium에 대한 Mechanism_Of_Action 정보 Not Available Magnesium에 대한 Mechanism_Of_Action 정보 Not Available
Pharmacology	Aluminium에 대한 Pharmacology 정보 Not Available
Protein Binding	Aluminium에 대한 단백결합 정보 Not Available
Half-life	Aluminium에 대한 반감기 정보 Not Available
Pharmacokinetics	Magnesium Carbonate의 약물동력학자료 흡수 : 경구 : 소량의 마그네슘이 위장관에서 흡수된다. 소실 : 대부분이 변배설되고, 흡수된 마그네슘은 신배설된다.
Biotransformation	Aluminium에 대한 Biotransformation 정보 Not Available
Drug Interactions	Aluminium에 대한 Drug_Interactions 정보 Cyclosporine Synercid increases the effect of cyclosporineAmlodipine This combination presents an increased risk of toxicityArsenic trioxide This combination presents an increased risk of toxicityAstemizole This combination presents an increased risk of toxicityAtorvastatin This combination presents an increased risk of toxicityCarbamazepine This combination presents an increased risk of toxicityCerivastatin This combination presents an increased risk of toxicityCisapride This combination presents an increased risk of toxicityClarithromycin This combination presents an increased risk of toxicityDelavirdine This combination presents an increased risk of toxicityDiazepam This combination presents an increased risk of toxicityDihydroquinidine barbiturate This combination presents an increased risk of toxicityDiltiazem This combination presents an increased risk of toxicityDisopyramide This combination presents an increased risk of toxicityDocetaxel This combination presents an increased risk of toxicityDofetilide This combination presents an increased risk of toxicityDroperidol This combination presents an increased risk of toxicityErythromycin This combination presents an increased risk of toxicityEtoposide This combination presents an increased risk of toxicityFelbamate This combination presents an increased risk of toxicityFelodipine This combination presents an increased risk of toxicityFlecainide This combination presents an increased risk of toxicityFoscarnet This combination presents an increased risk of toxicityFosphenytoin This combination presents an increased risk of toxicityGatifloxacin This combination presents an increased risk of toxicityGrepafloxacin This combination presents an increased risk of toxicityHalofantrine This combination presents an increased risk of toxicityIndinavir This combination presents an increased risk of toxicityIsradipine This combination presents an increased risk of toxicityLercanidipine This combination presents an increased risk of toxicityLevofloxacin This combination presents an increased risk of toxicityLosartan This combination presents an increased risk of toxicityLevomethadyl Acetate This combination presents an increased risk of toxicityLidocaine This combination presents an increased risk of toxicityLovastatin This combination presents an increased risk of toxicityMethylprednisolone This combination presents an increased risk of toxicityMidazolam This combination presents an increased risk of toxicityMoexipril This combination presents an increased risk of toxicityMoxifloxacin This combination presents an increased risk of toxicityNevirapine This combination presents an increased risk of toxicityNicardipine This combination presents an increased risk of toxicityNifedipine Synercid increases the effect of ziprasidoneNimodipine This combination presents an increased risk of toxicityNisoldipine This combination presents an increased risk of toxicityOctreotide This combination presents an increased risk of toxicityPaclitaxel This combination presents an increased risk of toxicityPentamidine This combination presents an increased risk of toxicityQuetiapine This combination presents an increased risk of toxicityQuinidine This combination presents an increased risk of toxicityQuinidine barbiturate This combination presents an increased risk of toxicityRitonavir This combination presents an increased risk of toxicitySalmeterol This combination presents an increased risk of toxicitySimvastatin This combination presents an increased risk of toxicityTacrolimus This combination presents an increased risk of toxicityTamoxifen This combination presents an increased risk of toxicityTeniposide This combination presents an increased risk of toxicityTerfenadine This combination presents an increased risk of toxicityTizanidine This combination presents an increased risk of toxicityVenlafaxine This combination presents an increased risk of toxicityVerapamil This combination presents an increased risk of toxicityVinblastine This combination presents an increased risk of toxicityVincristine This combination presents an increased risk of toxicityVindesine This combination presents an increased risk of toxicityVinorelbine This combination presents an increased risk of toxicity magnesium에 대한 Drug_Interactions 정보 Alendronate Formation of non-absorbable complexesCiprofloxacin Formation of non-absorbable complexesClodronate Formation of non-absorbable complexesDemeclocycline Formation of non-absorbable complexesDoxycycline Formation of non-absorbable complexesEnoxacin Formation of non-absorbable complexesEtidronic acid Formation of non-absorbable complexesGatifloxacin Formation of non-absorbable complexesGemifloxacin Formation of non-absorbable complexesGrepafloxacin Formation of non-absorbable complexesIbandronate Formation of non-absorbable complexesLevofloxacin Formation of non-absorbable complexesLomefloxacin Formation of non-absorbable complexesMethacycline Formation of non-absorbable complexesMinocycline Formation of non-absorbable complexesMoxifloxacin Formation of non-absorbable complexesNorfloxacin Formation of non-absorbable complexesOfloxacin Formation of non-absorbable complexesOxytetracycline Formation of non-absorbable complexesPefloxacin Formation of non-absorbable complexesRisedronate Formation of non-absorbable complexesTrovafloxacin Formation of non-absorbable complexesTetracycline Formation of non-absorbable complexesTemafloxacin Formation of non-absorbable complexesAmprenavir The antiacid decreases the absorption of amprenavirChloroquine The antiacid decreases the absorption of chloroquineAtazanavir This gastric pH modifier decreases the levels/effects of atazanavirDelavirdine The antiacid decreases the absorption of delavirdineDihydroquinidine barbiturate The antiacid decreases the absorption of quinidineFosamprenavir The antiacid decreases the absorption of amprenavirIndinavir The antiacid decreases the absorption of indinavirQuinidine The antiacid decreases the absorption of quindineQuinidine barbiturate The antiacid decreases the absorption of quinidinePolystyrene sulfonate Risk of alkalosis in renal impairmentRosuvastatin The antiacid decreases the absorption of rosuvastatin Magnesium에 대한 Drug_Interactions 정보 Alendronate Formation of non-absorbable complexesCiprofloxacin Formation of non-absorbable complexesClodronate Formation of non-absorbable complexesDemeclocycline Formation of non-absorbable complexesDoxycycline Formation of non-absorbable complexesEnoxacin Formation of non-absorbable complexesEtidronic acid Formation of non-absorbable complexesGatifloxacin Formation of non-absorbable complexesGemifloxacin Formation of non-absorbable complexesGrepafloxacin Formation of non-absorbable complexesIbandronate Formation of non-absorbable complexesLevofloxacin Formation of non-absorbable complexesLomefloxacin Formation of non-absorbable complexesMethacycline Formation of non-absorbable complexesMinocycline Formation of non-absorbable complexesMoxifloxacin Formation of non-absorbable complexesNorfloxacin Formation of non-absorbable complexesOfloxacin Formation of non-absorbable complexesOxytetracycline Formation of non-absorbable complexesPefloxacin Formation of non-absorbable complexesRisedronate Formation of non-absorbable complexesTrovafloxacin Formation of non-absorbable complexesTetracycline Formation of non-absorbable complexesTemafloxacin Formation of non-absorbable complexesAmprenavir The antiacid decreases the absorption of amprenavirChloroquine The antiacid decreases the absorption of chloroquineAtazanavir This gastric pH modifier decreases the levels/effects of atazanavirDelavirdine The antiacid decreases the absorption of delavirdineDihydroquinidine barbiturate The antiacid decreases the absorption of quinidineFosamprenavir The antiacid decreases the absorption of amprenavirIndinavir The antiacid decreases the absorption of indinavirQuinidine The antiacid decreases the absorption of quindineQuinidine barbiturate The antiacid decreases the absorption of quinidinePolystyrene sulfonate Risk of alkalosis in renal impairmentRosuvastatin The antiacid decreases the absorption of rosuvastatin
CYP450 Drug Interaction	[CYP450 Table직접조회]
Drug Target	[Drug Target]
Description	Aluminium에 대한 Description 정보 A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. [PubChem] magnesium에 대한 Description 정보 Magnesium hydroxide is used primarily in "Milk of Magnesia", a white aqueous, mildly alkaline suspension of magnesium hydroxide formulated at about 8%w/v. Milk of magnesia is primarily used to alleviate constipation, but can also be used to relieve indigestion and heartburn. When taken internally by mouth as a laxative, the osmotic force of the magnesia suspension acts to draw fluids from the body and to retain those already within the lumen of the intestine, serving to distend the bowel, thus stimulating nerves within the colon wall, inducing peristalsis and resulting in evacuation of colonic contents. Magnesium에 대한 Description 정보 Magnesium hydroxide is used primarily in "Milk of Magnesia", a white aqueous, mildly alkaline suspension of magnesium hydroxide formulated at about 8%w/v. Milk of magnesia is primarily used to alleviate constipation, but can also be used to relieve indigestion and heartburn. When taken internally by mouth as a laxative, the osmotic force of the magnesia suspension acts to draw fluids from the body and to retain those already within the lumen of the intestine, serving to distend the bowel, thus stimulating nerves within the colon wall, inducing peristalsis and resulting in evacuation of colonic contents.
Drug Category	Aluminium에 대한 Drug_Category 정보 Not Available magnesium에 대한 Drug_Category 정보 Not Available Magnesium에 대한 Drug_Category 정보 Not Available
Smiles String Canonical	Aluminium에 대한 Smiles_String_canonical 정보 [Al] magnesium에 대한 Smiles_String_canonical 정보 [Mg++] Magnesium에 대한 Smiles_String_canonical 정보 [Mg++]
Smiles String Isomeric	Aluminium에 대한 Smiles_String_isomeric 정보 [Al] magnesium에 대한 Smiles_String_isomeric 정보 [Mg++] Magnesium에 대한 Smiles_String_isomeric 정보 [Mg++]
InChI Identifier	Aluminium에 대한 InChI_Identifier 정보 InChI=1/Al magnesium에 대한 InChI_Identifier 정보 InChI=1/Mg/q+2 Magnesium에 대한 InChI_Identifier 정보 InChI=1/Mg/q+2
Chemical IUPAC Name	Aluminium에 대한 Chemical_IUPAC_Name 정보 aluminum magnesium에 대한 Chemical_IUPAC_Name 정보 magnesium(+2) cation Magnesium에 대한 Chemical_IUPAC_Name 정보 magnesium(+2) cation

사용자컨텐츠

항목

내용

핵심 요약 정보